Understanding “Ozempic Face” | Dr. David Rapaport Explains

Описание: Understanding “Ozempic Face”: What Really Happens When You Lose Weight Quickly

In this video, Dr. David Rapaport, board-certified plastic surgeon and founder of Athos in New York City, breaks down the truth behind what many now call “Ozempic Face.”

If you're taking GLP-1 medications like Ozempic, Wegovy, or Mounjaro and experiencing rapid weight loss, you may notice changes in your facial appearance—hollowness, sagging, or laxity. Dr. Rapaport explains why this happens and what you can realistically do about it.

From age-related fat loss, to the impact of skin laxity, to comparing non-invasive treatments like Softwave, Morpheus, and Eloor, he offers guidance on what works, what doesn't, and when a facelift becomes the most effective option.

In this video Dr. Rapaport explains:

-What “Ozempic Face” actually is and why rapid weight loss accelerates facial deflation

-How aging naturally causes fat loss and skin laxity—and how GLP-1 medications amplify these effects

-Why volume loss in areas like the temples and cheeks can cause a hollow or aged appearance

-The difference between fillers, skin tightening, and surgical options

-Why he prefers Sofwave over Morpheus for non-invasive tightening

-The risks of energy-based devices, including unintended fat loss

-How Ellacor works by removing tiny micro-dots of skin without energy or scarring

-When nonsurgical treatments are enough—and when a facelift may be the right option

-Realistic expectations for tightening treatments versus surgical results

-If you're dealing with facial changes during weight loss or trying to understand your treatment options, this breakdown gives you a balanced, realistic perspective straight from an experienced facial plastic surgeon.

Subscribe for more insights on facial aesthetics, aging, and advanced treatment options.